Blood test may help identify which colon cancer patients benefit from NSAIDs

Mail-out colorectal cancer screening programs extend, rather than replace, clinical care

As a gastroenterologist, I’ve had the sobering experience of delivering a colorectal cancer diagnosis for far too many patients and family members. Some meant to get screened but never found the time. Others thought it didn’t apply to them or assumed it would be too inconvenient.

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

GLP-1 receptor agonists—the class of drugs behind Ozempic, Wegovy, and Mounjaro—may do more than regulate blood sugar and weight.

November 21, 2025

Vol.51 No.43

Clinical Roundup

ChristianaCare research reveals drivers behind advanced breast cancer in hotspots

Reduced screening rates and a higher prevalence of triple-negative breast cancer are driving elevated rates of advanced breast cancer in a geographic hotspot in Wilmington, Delaware, according to findings by researchers at ChristianaCare’s Cawley Center for Translational Cancer Research at the Helen F. Graham Cancer Center & Research Institute.

July 25, 2025

Vol.51 No.29

Clinical

CRC patients with cannabis use disorder may have higher odds of death within five years of diagnosis
Observational study suggests that clinicians should be cautious when recommending cannabis to manage cancer symptoms

Cannabis use disorder is associated with a dramatically increased odds of death within five years of diagnosis in people with colorectal cancer, a recent observational study found.

Peptide drug shows promise in treating glioblastoma, Virginia Tech researchers find

A lab-designed molecule developed and extensively studied by scientists with Virginia Tech’s Fralin Biomedical Research Institute at VTC could represent a breakthrough in slowing tumor recurrence in glioblastoma, an aggressive and deadly form of brain cancer.

June 06, 2025

Vol.51 No.22

Drugs & Targets

Cardiac CT scanner receives FDA clearance

Arineta, a provider of cardiovascular imaging solutions, announced that its SpotLight Duo cardiac CT scanner has received 510(k) clearance from FDA for low-dose lung cancer screening. This clearance allows providers to use a single ultra-fast CT platform for both cardiac and lung imaging and diagnostics, delivering more complete care to high-risk patients.

May 23, 2025

Vol.51 No.20

Blood test may help identify which colon cancer patients benefit from NSAIDs

YOU MAY BE INTERESTED IN

Mail-out colorectal cancer screening programs extend, rather than replace, clinical care

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

ChristianaCare research reveals drivers behind advanced breast cancer in hotspots

CRC patients with cannabis use disorder may have higher odds of death within five years of diagnosis
Observational study suggests that clinicians should be cautious when recommending cannabis to manage cancer symptoms

Peptide drug shows promise in treating glioblastoma, Virginia Tech researchers find

Cardiac CT scanner receives FDA clearance

Renew today!

Subscriber content

Never miss an issue!

Login

Blood test may help identify which colon cancer patients benefit from NSAIDs

YOU MAY BE INTERESTED IN

Mail-out colorectal cancer screening programs extend, rather than replace, clinical care

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

ChristianaCare research reveals drivers behind advanced breast cancer in hotspots

CRC patients with cannabis use disorder may have higher odds of death within five years of diagnosisObservational study suggests that clinicians should be cautious when recommending cannabis to manage cancer symptoms

Peptide drug shows promise in treating glioblastoma, Virginia Tech researchers find

Cardiac CT scanner receives FDA clearance

Never miss an issue!

Login

CRC patients with cannabis use disorder may have higher odds of death within five years of diagnosis
Observational study suggests that clinicians should be cautious when recommending cannabis to manage cancer symptoms